BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Masola V, Zaza G, Gambaro G, Franchi M, Onisto M. Role of heparanase in tumor progression: Molecular aspects and therapeutic options. Semin Cancer Biol 2020;62:86-98. [PMID: 31348993 DOI: 10.1016/j.semcancer.2019.07.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Karamanos NK, Theocharis AD, Piperigkou Z, Manou D, Passi A, Skandalis SS, Vynios DH, Orian-Rousseau V, Ricard-Blum S, Schmelzer CEH, Duca L, Durbeej M, Afratis NA, Troeberg L, Franchi M, Masola V, Onisto M. A guide to the composition and functions of the extracellular matrix. FEBS J 2021. [PMID: 33605520 DOI: 10.1111/febs.15776] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
2 Li S, Fu H, Wang Y, Wang L, Jia B, Bian Y. Curcumin inhibits CT26 cells metastasis by decreasing heparanase expression. J Leukoc Biol 2020;108:1727-33. [PMID: 32640496 DOI: 10.1002/JLB.1MA0620-357R] [Reference Citation Analysis]
3 Masola V, Greco N, Gambaro G, Franchi M, Onisto M. Heparanase as active player in endothelial glycocalyx remodeling. Matrix Biol Plus 2022;13:100097. [PMID: 35036899 DOI: 10.1016/j.mbplus.2021.100097] [Reference Citation Analysis]
4 Ravi Kiran AVVV, Kusuma Kumari G, Krishnamurthy PT, Khaydarov RR. Tumor microenvironment and nanotherapeutics: intruding the tumor fort. Biomater Sci 2021;9:7667-704. [PMID: 34673853 DOI: 10.1039/d1bm01127h] [Reference Citation Analysis]
5 Piperigkou Z, Kyriakopoulou K, Koutsakis C, Mastronikolis S, Karamanos NK. Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer. Cancers (Basel) 2021;13:1441. [PMID: 33809973 DOI: 10.3390/cancers13061441] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Belvedere R, Novizio N, Pessolano E, Tosco A, Eletto D, Porta A, Campiglia P, Perretti M, Filippelli A, Petrella A. Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells. Biochemical Pharmacology 2020;182:114252. [DOI: 10.1016/j.bcp.2020.114252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Tang WQ, Hei Y, Lin J. Heparanase-1 is downregulated in chemoradiotherapy orbital rhabdomyosarcoma and relates with tumor growth as well as angiogenesis. Int J Ophthalmol 2022;15:31-9. [PMID: 35047353 DOI: 10.18240/ijo.2022.01.05] [Reference Citation Analysis]
8 Masola V, Zaza G, Arduini A, Onisto M, Gambaro G. Endothelial Glycocalyx as a Regulator of Fibrotic Processes. Int J Mol Sci 2021;22:2996. [PMID: 33804258 DOI: 10.3390/ijms22062996] [Reference Citation Analysis]
9 Cao H, Yang S, Yu X, Xi M. Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer. Mol Genet Genomic Med 2020;8:e1257. [PMID: 32869952 DOI: 10.1002/mgg3.1257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Gross-Cohen M, Yanku Y, Kessler O, Barash U, Boyango I, Cid-Arregui A, Neufeld G, Ilan N, Vlodavsky I. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression. Matrix Biol 2021;99:58-71. [PMID: 34004353 DOI: 10.1016/j.matbio.2021.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Majo S, Courtois S, Souleyreau W, Bikfalvi A, Auguste P. Impact of Extracellular Matrix Components to Renal Cell Carcinoma Behavior. Front Oncol 2020;10:625. [PMID: 32411604 DOI: 10.3389/fonc.2020.00625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Whitefield C, Hong N, Mitchell JA, Jackson CJ. Computational design and experimental characterisation of a stable human heparanase variant. RSC Chem Biol . [DOI: 10.1039/d1cb00239b] [Reference Citation Analysis]
13 Lanzi C, Favini E, Dal Bo L, Tortoreto M, Arrighetti N, Zaffaroni N, Cassinelli G. Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma. J Exp Clin Cancer Res 2021;40:381. [PMID: 34857011 DOI: 10.1186/s13046-021-02150-y] [Reference Citation Analysis]
14 Ginini L, Billan S, Fridman E, Gil Z. Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate. Cells 2022;11:1375. [DOI: 10.3390/cells11091375] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ma X, Wang X, Chen Q, He H, Sun Y, Liu H, Wang Y, Qu J, Huang F. Glycosaminoglycan / gold nanocluster hybrid nanoparticles as a new sensing platform: Metastatic potential assessment of cancer cells. Carbohydrate Polymers 2020;230:115654. [DOI: 10.1016/j.carbpol.2019.115654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Meng Y, Sun J, Qv N, Zhang G, Yu T, Piao H. Application of molecular imaging technology in tumor immunotherapy. Cellular Immunology 2020;348:104039. [DOI: 10.1016/j.cellimm.2020.104039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Lanzi C, Cassinelli G. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities. Biochemical Pharmacology 2020;178:114084. [DOI: 10.1016/j.bcp.2020.114084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Boyce A, Walsh G. Production, characteristics and applications of microbial heparinases. Biochimie 2022. [DOI: 10.1016/j.biochi.2022.03.011] [Reference Citation Analysis]
19 Chen CG, Iozzo RV. Extracellular matrix guidance of autophagy: a mechanism regulating cancer growth. Open Biol 2022;12:210304. [PMID: 34982945 DOI: 10.1098/rsob.210304] [Reference Citation Analysis]
20 Couchman JR. Syndecan-1 (CD138), Carcinomas and EMT. Int J Mol Sci 2021;22:4227. [PMID: 33921767 DOI: 10.3390/ijms22084227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Jayatilleke KM, Hulett MD. Heparanase and the hallmarks of cancer. J Transl Med 2020;18:453. [PMID: 33256730 DOI: 10.1186/s12967-020-02624-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
22 Knani I, Singh P, Gross-Cohen M, Aviram S, Ilan N, Sanderson RD, Aronheim A, Vlodavsky I. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3. Matrix Biol 2021:S0945-053X(21)00105-0. [PMID: 34808335 DOI: 10.1016/j.matbio.2021.11.001] [Reference Citation Analysis]
23 Groult H, Carregal-Romero S, Castejón D, Azkargorta M, Miguel-Coello AB, Pulagam KR, Gómez-Vallejo V, Cousin R, Muñoz-Caffarel M, Lawrie CH, Llop J, Piot JM, Elortza F, Maugard T, Ruiz-Cabello J, Fruitier-Arnaudin I. Heparin length in the coating of extremely small iron oxide nanoparticles regulates in vivo theranostic applications. Nanoscale 2021;13:842-61. [PMID: 33351869 DOI: 10.1039/d0nr06378a] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Wang H, You Y, Zhu X. The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies. Front Oncol 2022;12:887518. [DOI: 10.3389/fonc.2022.887518] [Reference Citation Analysis]
25 Yang C, Zhang S, Chang X, Huang Y, Cui D, Liu Z. MicroRNA-219a-2-3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway. Exp Ther Med 2021;21:659. [PMID: 33968189 DOI: 10.3892/etm.2021.10091] [Reference Citation Analysis]
26 Wang C, Wei Y, Wang G, Zhou Y, Zhang J, Xu K. Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition through the Wnt/β‑catenin pathway. Oncol Rep 2020;44:711-21. [PMID: 32627022 DOI: 10.3892/or.2020.7641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Li QW, Zhang GL, Hao CX, Ma YF, Sun X, Zhang Y, Cao KX, Li BX, Yang GW, Wang XM. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer. J Ethnopharmacol 2021;266:113430. [PMID: 33011366 DOI: 10.1016/j.jep.2020.113430] [Reference Citation Analysis]
28 Yang LF, Yang F, Zhang FL, Xie YF, Hu ZX, Huang SL, Shao ZM, Li DQ. Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis. Theranostics 2020;10:5242-58. [PMID: 32373210 DOI: 10.7150/thno.43744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
29 Jiang S, Fu R, Shi J, Wu H, Mai J, Hua X, Chen H, Liu J, Lu M, Li N. CircRNA-Mediated Regulation of Angiogenesis: A New Chapter in Cancer Biology. Front Oncol 2021;11:553706. [PMID: 33777729 DOI: 10.3389/fonc.2021.553706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]